Please login first
Seok-Ki Kim  - - - 
Top co-authors See all
Keon Wook Kang

191 shared publications

Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea

Sang Soo Kim

161 shared publications

Center for Proton Therapy, Research Institute and Hospital, National Cancer Center, Goyang 410-769, Korea

Kwan H. Cho

74 shared publications

Proton Therapy Center, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, Republic of Korea

June-Key Chung

54 shared publications

Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea

Sun-Young Kong

39 shared publications

Department of Laboratory Medicine, Center for Diagnostic Oncology, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea

74
Publications
0
Reads
0
Downloads
325
Citations
Publication Record
Distribution of Articles published per year 
(1999 - 2019)
Total number of journals
published in
 
33
 
Publications See all
Article 0 Reads 0 Citations Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer Hyunjong Lee, Dong-Eun Lee, Sohyun Park, Tae Sung Kim, So-Yo... Published: 01 January 2019
Clinical Nuclear Medicine, doi: 10.1097/rlu.0000000000002348
DOI See at publisher website
Article 0 Reads 0 Citations 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction ... Sohyun Park, Tae-Sung Kim, Se Hun Kang, Hyun Beom Kim, Joong... Published: 14 September 2018
Medicine, doi: 10.1097/MD.0000000000012311
DOI See at publisher website ABS Show/hide abstract
Supplemental Digital Content is available in the text
Article 0 Reads 0 Citations 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction ... Sohyun Park, Tae-Sung Kim, Se Hun Kang, Hyun Beom Kim, Joong... Published: 01 September 2018
Medicine,
PubMed View at PubMed
Article 0 Reads 0 Citations Unusual Contralateral Axillary Lymph Node Metastasis in a Second Primary Breast Cancer Detected by FDG PET/CT and Lympho... Ji-Young Kim, Hyunjong Lee, Tae Sung Kim, Han-Sung Kang, Seo... Published: 11 August 2017
Nuclear Medicine and Molecular Imaging, doi: 10.1007/s13139-017-0485-6
DOI See at publisher website PubMed View at PubMed ABS Show/hide abstract
Contralateral metastatic axillary lymph nodes in a patient with breast cancer is a rare condition. Here, we present a 55-year-old woman with a second primary breast cancer. The patient underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for staging work-up. Additionally, preoperative lymphoscintigraphy was performed to detect sentinel lymph nodes. FDG PET/CT demonstrated increased FDG uptake in the left nipple and right axillary lymph nodes. Lymphoscintigraphy identified the right axillary lymph nodes which was consistent with the FDG PET/CT findings. This case emphasizes the usefulness of FDG PET/CT and lymphoscintigraphy for identifying unpredictable contralateral axillary lymph node metastasis from a second primary breast cancer.
Article 0 Reads 0 Citations Antigen-responsive molecular sensor enables real-time tumor-specific imaging Hyunjin Kim, Hak Soo Choi, Seok-Ki Kim, Byung Il Lee, Yongdo... Published: 23 February 2017
Theranostics, doi: 10.7150/thno.16647
DOI See at publisher website PubMed View at PubMed ABS Show/hide abstract
Antibody-fluorophore conjugates have high potential for the specific fluorescence detection of target cancer cells in vitro and in vivo. However, the antibody-fluorophore conjugates described to date are inappropriate for real-time imaging of target cells because removal of unbound antibody is required to reduce background fluorescence before quantifiable analysis by microscopy. In addition, clinical applications of the conjugates have been limited by persistent background retention due to their long systemic circulation and nonspecific uptake. Here we report fast and real-time near-infrared fluorescence imaging of target cancer cells using an antigen-responsive molecular “on-off” sensor: the fluorescence of trastuzumab-ATTO680 conjugate is dark (i.e., turned off) in the extracellular region, while it becomes highly fluorescent (i.e., turned on) upon binding to the target antigen HER2 on cancer cell surface. This molecular switch enables fast and real-time imaging of target cancer cells in vitro and in vivo.
Article 0 Reads 0 Citations Toward redesigning the PEG surface of nanocarriers for tumor targeting: impact of inner functionalities on size, charge,... Ju Young Heo, Se Hun Kang, Young-Hwa Kim, Suyeon You, Kyeong... Published: 01 January 2017
Chemical Science, doi: 10.1039/c6sc05640g
DOI See at publisher website PubMed View at PubMed ABS Show/hide abstract
A simple strategy to enhance the tumor-targeting efficiency of PEGylated nanocarriers is demonstrated.
Top